tiprankstipranks
Aviva (AVVIY)
OTHER OTC:AVVIY

Aviva (AVVIY) AI Stock Analysis

177 Followers

Top Page

AVVIY

Aviva

(OTC:AVVIY)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 5.2)
Rating:62Neutral
Price Target:
$18.00
▲(4.59% Upside)
Action:ReiteratedDate:03/08/26
The score reflects strong valuation support (low P/E and high dividend) and a constructive earnings-call outlook (capital strength, buyback/dividend growth, and clear multi-year targets), offset by weaker technical momentum and a fundamental risk from inconsistent cash-flow generation and thin/variable profitability.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for Aviva's products and services, enhancing its market position and potential for future expansion.
Negative Factors
Declining Profitability Margins
Declining margins may indicate rising costs or inefficiencies, potentially impacting long-term profitability and competitiveness.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Strong revenue growth indicates robust demand for Aviva's products and services, enhancing its market position and potential for future expansion.
Read all positive factors

Aviva (AVVIY) vs. SPDR S&P 500 ETF (SPY)

Aviva Business Overview & Revenue Model

Company Description
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annui...
How the Company Makes Money
Aviva generates revenue through multiple key streams, primarily from premiums collected from its insurance policies, which include life, health, and property insurance. The company also earns significant income from its asset management services, ...

Aviva Earnings Call Summary

Earnings Call Date:Mar 05, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Aug 06, 2026
Earnings Call Sentiment Positive
The call presents a strongly positive operating and capital position: management beat near‑term targets early, reported robust profit and capital metrics (operating profit +25%, EPS ahead of baseline, solvency c.180%), raised ambitions and resumed shareholder returns (dividend +10%, GBP 350m buyback). Wealth, GI and AI-driven efficiency gains are clear growth and margin levers. The key risks highlighted are cyclical underwriting volatility (large losses, weather), short-term drag and execution risk from Direct Line integration, some reduced protection sales, and competitive pressures in bulk annuities/Commercial Lines. Overall the positives — delivered results, capital strength, clear synergy and AI upside, and upgraded targets — substantially outweigh the manageable near-term challenges.
Positive Updates
Strong overall financial performance
Operating profit rose 25% to GBP 2.2 billion; basic operating EPS was 56p (ahead of the 55p baseline); IFRS return on equity was 17.5%. Cash remittances increased 4% to GBP 2.1 billion and own funds generation (OFG) was GBP 2.3 billion. Solvency cover was strong at c.180%.
Negative Updates
Combined ratio and underwriting headwinds remain cyclical
Underlying combined ratio pressure noted (Charlotte cited underlying COR rising to c.96.7% in some measures) and group COR was 94.6% in 2025. Management’s pledge to deliver 'better than 94%' in 2026 depends on prior-year development, improved large-loss experience, normal weather and full-year benefits from rate/actions - none of which are guaranteed.
Read all updates
Q4-2025 Updates
Negative
Strong overall financial performance
Operating profit rose 25% to GBP 2.2 billion; basic operating EPS was 56p (ahead of the 55p baseline); IFRS return on equity was 17.5%. Cash remittances increased 4% to GBP 2.1 billion and own funds generation (OFG) was GBP 2.3 billion. Solvency cover was strong at c.180%.
Read all positive updates
Company Guidance
The call reiterated near‑term and 3‑year guidance: Aviva has already met its 2026 targets and expects U.K. & Ireland General Insurance to deliver a combined ratio better than 94% in 2026 (group COR was 94.6% in 2025; underlying 96.7%), Canada’s COR is expected to approach 94%, and the group is targeting an 11% operating EPS CAGR from 2025–2028 (55p baseline to ~75p by 2028; 2025 EPS was 56p). Financial and capital guidance included a resumed GBP 350m share buyback, a final dividend of 26.2p (total 39.3p, +10% y/y), solvency back to c.180% supported by GBP 2.3bn OFG, delivery of at least GBP 350m (c.7 points) of solvency benefit from Direct Line synergies by year‑end and a progressive operating capital generation build of ~20 points in 2027. Business targets reiterated: GBP 280m Wealth profit ambition by 2027, further acceleration beyond 75% capital‑light, Direct Line cost savings uplift to GBP 225m (GBP 100m achieved; GBP 50m delivered in H2 2025; remaining GBP 175m over next 3 years), and continued investment (including ~GBP 50m to unlock ≥GBP 50m p.a. claims benefits) to drive productivity and AI‑enabled improvements.

Aviva Financial Statement Overview

Summary
Mixed fundamentals: balance sheet strength is relatively solid (improving debt-to-equity and steady positive ROE), but profitability is thin and volatile and cash flow is the key weakness with operating/free cash flow flipping negative in multiple recent years, reducing earnings visibility.
Income Statement
58
Neutral
Balance Sheet
67
Positive
Cash Flow
42
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue57.44B22.74B21.58B16.20B16.66B
Gross Profit58.84B22.74B40.76B-20.72B16.66B
EBITDA2.06B1.58B2.03B-887.00M1.33B
Net Income1.03B683.00M1.08B-1.05B1.97B
Balance Sheet
Total Assets395.30B353.88B328.84B315.32B358.47B
Cash, Cash Equivalents and Short-Term Investments18.55B23.48B17.27B22.50B12.48B
Total Debt7.31B6.89B7.37B8.07B8.47B
Total Liabilities384.21B345.26B319.24B302.42B339.02B
Stockholders Equity10.69B8.30B9.28B9.90B19.20B
Cash Flow
Free Cash Flow-2.75B8.27B-3.08B15.78B-2.97B
Operating Cash Flow-2.56B8.45B-2.73B15.88B-2.86B
Investing Cash Flow-1.14B162.00M-350.00M-339.00M74.00M
Financing Cash Flow-2.04B-2.49B-1.82B-5.94B-4.40B

Aviva Technical Analysis

Technical Analysis Sentiment
Positive
Last Price17.21
Price Trends
50DMA
16.47
Positive
100DMA
16.70
Positive
200DMA
16.72
Positive
Market Momentum
MACD
>-0.01
Negative
RSI
59.20
Neutral
STOCH
79.50
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AVVIY, the sentiment is Positive. The current price of 17.21 is above the 20-day moving average (MA) of 16.09, above the 50-day MA of 16.47, and above the 200-day MA of 16.72, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 59.20 is Neutral, neither overbought nor oversold. The STOCH value of 79.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVVIY.

Aviva Risk Analysis

Aviva disclosed 15 risk factors in its most recent earnings report. Aviva reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Aviva Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
84
Outperform
$35.08B7.1519.02%16.68%-28.54%
79
Outperform
$38.32B10.1421.37%1.55%7.11%22.52%
73
Outperform
$20.43B9.4910.26%3.44%12.33%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
$41.55B15.627.50%2.02%-23.02%52.43%
65
Neutral
$11.60B10.9211.63%5.77%-6.19%
62
Neutral
$25.57B19.2410.20%5.27%-17.44%-52.47%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AVVIY
Aviva
16.96
5.44
47.25%
AEG
Aegon
7.78
2.25
40.74%
AIG
American International Group
77.43
-2.13
-2.68%
ACGL
Arch Capital Group
98.60
8.02
8.85%
HIG
Hartford Insurance
138.90
26.00
23.03%
PFG
Principal Financial
94.20
24.92
35.97%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 08, 2026